On Air Now

Current Show

Early Morning Journal   5:30 AM - 6:00 AM

The latest information to get your morning going on the Early Morning Journal

Show Info »

Upcoming Shows

Program Schedule »

Tune in to Listen

1590 AM Coldwater, Michigan 95.5 FM Coldwater, Michigan

Weather

Current Conditions(Coldwater,MI 49036)

More Weather »
47° Feels Like: 42°
Wind: WSW 9 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Rain 59°

Tonight

Mostly Clear 43°

Tomorrow

Mostly Sunny 60°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

GSK's Tafinlar named as FDA breakthrough therapy for lung cancer

The logo of GlaxoSmithKline (GSK) is seen on its office building in Shanghai July 12, 2013. REUTERS/Aly Song
The logo of GlaxoSmithKline (GSK) is seen on its office building in Shanghai July 12, 2013. REUTERS/Aly Song

LONDON (Reuters) - British pharmaceutical company GlaxoSmithKline said its Tafinlar cancer treatment had been given FDA breakthrough therapy designation for lung cancer, meaning the drug will be fast-tracked within the U.S. regulatory system.

GSK said that Tafinlar, also known as dabrafenib, was designated an FDA breakthrough therapy on Monday following interim results from an ongoing Phase II study.

Tafinlar is already approved for melanoma, the deadliest form of skin cancer.

(Reporting by Sarah Young, Editing by Paul Sandle)

Comments